fda warning bpc-157 unapproved peptide 2024 2025 Compliance for Therapy and – Holt Law FDA to Remove 12 Popular

UK REACH and Workplace Controls Where a peptide is lawfully handled as a laboratory chemical, additional duties may arise under chemical and workplace frameworks

GHK-Cu has a longer research history with more published dermatology studies examining collagen synthesis and matrix metalloproteinase inhibition, making it the reference standard for copper peptide formulations

On matrix remodeling they diverge: BPC-157 acts specifically on tendon fibroblast signaling, TB-500 acts transversally across all repairing tissues via actin dynamics

Each product is sterile, pharmaceutical-grade, and third-party tested for safety, potency, and purity